Abstract
Data presented here demonstrate that vaccine-induced CD8(+) T cells can eliminate their specific tumor-target with a two-staged attack. First, they release interferon-gamma that results in growth arrest of the tumor cells via induction of antiangiogenic mediators. Then, during the latter stages of the immune response, CD8(+) effector T cells eradicate the remaining tumor cells through perforin-mediated lysis. A combination of these two mechanisms is highly effective in the described model, while either pathway alone fails to completely achieve tumor rejection.
MeSH terms
-
Adenoviridae
-
Animals
-
CD8-Positive T-Lymphocytes / immunology*
-
CD8-Positive T-Lymphocytes / physiology
-
Cancer Vaccines / immunology*
-
Cancer Vaccines / pharmacology
-
Cell Division / drug effects
-
Humans
-
Interferon-gamma / metabolism*
-
Interferon-gamma / pharmacology
-
Lung Neoplasms / therapy*
-
Lung Neoplasms / veterinary
-
Membrane Glycoproteins / genetics
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neoplasms, Experimental
-
Neovascularization, Pathologic
-
Perforin
-
Pore Forming Cytotoxic Proteins
Substances
-
Cancer Vaccines
-
Membrane Glycoproteins
-
Pore Forming Cytotoxic Proteins
-
Perforin
-
Interferon-gamma